# Coyote Bioscience Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/coyote-bioscience-co

- Industry: Healthcare
- Headquarters: Beijing, China
- Website: www.coyotebio.com
- Total disclosed funding: $97M
- Latest round: Series D (Dec 23, 2020)
- Investors on record: 11

## About

Founded in 20009 and based in Beijing, China, Coyote Bioscience Co., Ltd. operates as a medical testing laboratory that covers a wide range of subject areas such as personalized medicine, cancer, infection, and infectious diseases that provides diagnosis and treatment integration.

## Funding rounds

- Series D, Dec 23, 2020, $92M — Frees Fund, Jinyuan Kuntong Equity Investment Management, GL Ventures, Grand Mount Capital
- Series D, Mar 28, 2019 — Longly Venture Capital
- Series C, Sep 22, 2017 — Chang'an Capital, Lapam Capital, New Founder Capital Management
- Series B, Jan 11, 2016 — SAIF Partners, NLVC, Legend Star
- Series A, Apr 1, 2014, $4.9M — SAIF Partners, Legend Star

## Investors

- SAIF Partners (https://capitalatlas.ai/funds/saif-partners) — Series A, Series B
- Legend Star (https://capitalatlas.ai/funds/legend-star) — Series A, Series B
- NLVC (https://capitalatlas.ai/funds/nlvc) — Series B
- Chang'an Capital (https://capitalatlas.ai/funds/chang-an-capital) — Series C
- Lapam Capital (https://capitalatlas.ai/funds/lapam-capital) — Series C
- New Founder Capital Management — Series C
- Longly Venture Capital (https://capitalatlas.ai/funds/longly-venture-capital) — Series D
- Frees Fund (https://capitalatlas.ai/funds/frees-fund) — Series D
- Jinyuan Kuntong Equity Investment Management (https://capitalatlas.ai/funds/jinyuan-kuntong-equity-investment-management) — Series D
- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series D
- Grand Mount Capital (https://capitalatlas.ai/funds/grand-mount-capital) — Series D